Home   >   Our Official Blog  >  Non-Hodgkin Lymphoma has a new name - ‘Roundup Cancer’

Non-Hodgkin Lymphoma has a new name - ‘Roundup Cancer’

By Gregory A. Cade

Posted on October 16th, 2018

A lot of people have come forward claiming that they have developed debilitating diseases after using Roundup and other glyphosate-based herbicides. We are here to help them and stand by them when they seek justice.

Non-Hodgkin's Lymphoma is commonly referred to as "Roundup cancer" after research has proven that glyphosate, an active ingredient of Monsanto's Roundup, an herbicide can cause this type of cancer. Dr. Charles William Jameson, Ph.D., a toxicology expert and one of the scientists involved in glyphosate research undertaken by the International Agency for Research on Cancer presented a testimony at the San Francisco Federal Court on March 7, 2018. He made it clear that oxidative stress from glyphosate-based herbicides causes Non-Hodgkin's Lymphoma and that it was credible information. He also mentioned that the glyphosate levels to which farmworkers get exposed while using the herbicide is enough to cause Non-Hodgkin's Lymphoma.

With the introduction of genetically engineered glyphosate-resistant crops in 1974, the use of this chemical has increased exponentially and it is quite alarming to know that as much as 300 million pounds of glyphosate-based herbicides are used in U.S farmlands each year. Over the last three decades, the number of reported cases of Non-Hodgkin's lymphoma has been increasing and Roundup weed killer is the major contributor for the rise in these cases. Around 5000 individuals including farmers and people working in the agriculture field have filed lawsuits against Monsanto, claiming that they have been diagnosed with Non-Hodgkin's Lymphoma as a result of occupational exposure to Roundup. On August 10, 2018, Dewayne Johnson, a former groundskeeper, won his claim in the world's first ever Roundup lawsuit verdict.

Roundup Is More Toxic Than Glyphosate Alone

Recently, the tests conducted by the U.S. National Toxicology Program have revealed that the use of Roundup formula is far more toxic than when glyphosate used alone. According to this study, Roundup alters the viability of human cells significantly by disrupting the functions of the cell membrane, in other words, Roundup can kill human cells. The pilot phase results of the global glyphosate study conducted at the Ramazzini Institute in Italy ascertains carcinogenicity of glyphosate and revealed genotoxic effects of daily ingestion of glyphosate.

Diagnosis and Treatment of Non-Hodgkin Lymphoma

Non-Hodgkin lymphoma is a type of cancer that forms in the white blood cells-B-lymphocytes, T- lymphocytes, and natural killer cells. About 80-90% of cases are found to be B-cell lymphomas, 15-20% cases are T-cell lymphomas, and natural killer lymphomas are quite rare. These type of tumors develop as a result of the chromosomal translocation, chronic inflammation, immunodeficiency conditions, infections, and environmental factors. Paying attention to the signs and symptoms that are most common in lymphoma is the simplest way to detect Non-Hodgkin lymphoma at an early stage. Watch out for an itchy, red/purple painless lump or bump below the skin, most commonly in the armpit, sides of the neck, or in the groin, which indicates enlarged lymph nodes. Other symptoms such as fever, chills, fatigue, weight loss, night sweats, abdominal pain/swelling, cough, difficulty breathing, chest pain, headache, and double vision may occur and get worse instead of getting better with time. The appearance of these signs should prompt a medical check-up to find out the exact cause of these symptoms. Often, a biopsy of the swollen lymph node will be recommended to confirm Non-Hodgkin's lymphoma. Other tests that may be performed, which include lab tests on biopsy samples and imaging tests (X-rays, CT scan, MRI scan, ultrasound, bone scan, and positron emission tomography scan). Blood and urine tests may be done to rule out an infection.

A multidisciplinary team of doctors including medical oncologist or hematologist, radiation oncologist, and bone marrow transplant doctor works together to ensure a successful outcome. The treatment plan is developed based on the factors such as the patient's age, general health, extent and the subtype of Non-Hodgkin's Lymphoma. In most cases, chemotherapy alone or in a combination of immunotherapy or radiation therapy will be provided. Chemotherapy involves administration of anti-cancer drugs into a vein or orally. Immunotherapy employs monoclonal antibodies that have been designed to attack specific antigen targets on the surface of lymphocytes. Radiation therapy helps kill cancer cells with a focused beam of high-energy X-rays. Targeted drugs are newer treatment methods that have fewer side effects. Surgery is performed only in a few conditions, usually to obtain a biopsy sample and classify the lymphoma.

Non-Hodgkin's lymphoma may sometimes remain obscure until it reaches advanced stages. It may prove to be fatal if diagnosed at later stages. Therefore, it is better we reduce exposure to known carcinogens and risk factors.

Sources: